NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Actavis plc, a leading global specialty pharmaceutical company, and the owners of Auden Mckenzie Holdings Limited, a dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK, today announced that they have reached a definitive agreement, under which…

news

NPS Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of therapeutic products, announced Friday that its drug Natpara for rare hormonal disorder has won the US Food and Drug Administration’s (FDA) approval, endorsing a bet by Shire PLC (ADR) on the drug’s approval and thus validating the company’s $5.2…

news

Lixte Biotechnology Holdings, Inc. (LIXT), announced that the number of clinical sites where its Phase I trial of Lixte's lead compound, LB?100, is being conducted, has been expanded from 1 to 5 institutions. John S. Kovach, M.D., the founder and President of Lixte, said that, "the initial trial was planned…

news

A St. Louis pharmaceutical company had to be evacuated after a chemical spill Thursday night. Mallinckrodt, located in the 3600 block of North Second Street, was evacuated at 9:00 p.m. after about 20 gallons of Toluene was spilled inside the facility. Officials say the spill occurred during a normal process…

news

Legacy Pharmaceutical Packaging, a contract packager serving the global pharmaceutical industry with bottling, blistering, pouching, unit-of-use, compliance and secondary packaging services, made two key executive hires to close 2014, and to help increase business at its newly expanded facility:  Steve Meeker, was named the new COO. He has more than…

news

Sen. Elizabeth Warren took the populist ire she usually reserves for Wall Street banks and directed it Thursday at drug companies that are making billion-dollar profits. Addressing a leading health reform advocacy group, the Massachusetts Democrat lambasted pharmaceutical firms that are “making money by skirting the law” even while relying…

news

Indian Prime Minister Narendra Modi is about to launch a universal healthcare scheme. Since as much as a quarter of India's 1.2 billion people lack access to medicine, that sounds like happy news for drug makers. Yet the plan bodes ill for efforts to improve the country's unreliable patent protections.…

news

Days before President Barack Obama arrives in India, foreign drug makers, including the large American ones have lobbied the government to make it easier for them to invest in the country's pharmaceutical sector. They want 100% foreign direct investment (FDI) to be allowed in existing companies through the automatic route.…

news

An Indian pharmaceutical company is considering a $9.5 million expansion for its Monroe manufacturing plant even before production begins in April. Glenmark Pharmaceuticals expects to make a decision this month among several sites for its expansion, said Chris Platé, executive director for Monroe-Union County Economic Development. In July, the company…

news

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced today that it has dosed the first subject in a Phase I clinical trial of TKM-HBV, a therapeutic agent designed to reduce hepatitis B surface antigen in patients chronically infected with hepatitis B virus (HBV). "We are pleased…